Why the study?
It remained unclear whether a prehospital rule-out strategy using the HEART score and a point-of-care troponin measurement in patients with suspected NSTE-ACS is cost-effective.
Does a prehospital rule-out strategy using the HEART score and a POC troponin measurement improve cost-effectiveness in low-risk patients suspected of NSTE-ACS?
Population
866 low-risk patients suspected of NSTE-ACS
Comparison
Prehospital POC troponin T and GP transfer vs ED presentation
Design
Randomised trial
Follow-up
30 days, 6 months and 12 months
Authors
Loading...
Establishes RCT framework for prehospital NSTE-ACS rule-out; leaves open cost-effectiveness until results reported.
Does a prehospital rule-out strategy using the HEART score and a POC troponin measurement improve cost-effectiveness in low-risk patients suspected of NSTE-ACS?
The ARTICA trial is designed to evaluate the cost-effectiveness of a prehospital rule-out strategy for NSTE-ACS using the HEART score and point-of-care troponin T.
Aarts et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: